Topotecan Completed Phase 1 Trials for Myelodysplastic Syndromes / Leukemias Treatment

IndicationsStatusPurposePhase
CompletedTreatment1
clinicaltrials.gov IdentifierTitleDrugs
NCT00002588Combination Chemotherapy in Treating Patients With Recurrent or Refractory Leukemia
NCT00002705Topotecan in Treating Children With Refractory Leukemia
NCT00005593Fludarabine, Carboplatin, and Topotecan in Treating Patients With Relapsed/Refractory Acute Leukemia or Advanced Myelodysplastic Syndrome
NCT00462787Combination Chemotherapy in Treating Young Patients With Relapsed or Refractory Acute Leukemia